Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
INNV vs CCRN vs ALHC vs AMN vs UNH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Healthcare Plans
Medical - Care Facilities
Medical - Healthcare Plans
INNV vs CCRN vs ALHC vs AMN vs UNH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Healthcare Plans | Medical - Care Facilities | Medical - Healthcare Plans |
| Market Cap | $1.10B | $423M | $3.73B | $869M | $335.60B |
| Revenue (TTM) | $946M | $761M | $4.26B | $3.42B | $449.71B |
| Net Income (TTM) | $-22M | $-99M | $20M | $-32M | $12.04B |
| Gross Margin | 14.8% | 18.2% | 9.0% | 25.5% | 18.8% |
| Operating Margin | 1.5% | -0.9% | 0.8% | 0.3% | 4.2% |
| Forward P/E | 32.0x | 133.8x | 140.9x | 11.0x | 20.2x |
| Total Debt | $101M | $2M | $338M | $803M | $78.39B |
| Cash & Equiv. | $64M | $109M | $578M | $34M | $24.36B |
INNV vs CCRN vs ALHC vs AMN vs UNH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| InnovAge Holding Co… (INNV) | 100 | 31.3 | -68.7% |
| Cross Country Healt… (CCRN) | 100 | 104.8 | +4.8% |
| Alignment Healthcar… (ALHC) | 100 | 83.2 | -16.8% |
| AMN Healthcare Serv… (AMN) | 100 | 30.5 | -69.5% |
| UnitedHealth Group … (UNH) | 100 | 99.4 | -0.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: INNV vs CCRN vs ALHC vs AMN vs UNH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
INNV is the #2 pick in this set and the best alternative if momentum is your priority.
- +147.9% vs CCRN's -5.4%
CCRN is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.78, Low D/E 0.7%, current ratio 3.78x
ALHC ranks third and is worth considering specifically for growth exposure and defensive.
- Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
- Beta 0.75, current ratio 1.74x
- 46.1% revenue growth vs CCRN's -21.6%
AMN is the clearest fit if your priority is value.
- Lower P/E (11.0x vs 140.9x)
UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 25 yrs, beta 0.59, yield 2.4%
- 220.6% 10Y total return vs ALHC's 5.4%
- 2.7% margin vs CCRN's -13.0%
- Beta 0.59 vs INNV's 1.66
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 46.1% revenue growth vs CCRN's -21.6% | |
| Value | Lower P/E (11.0x vs 140.9x) | |
| Quality / Margins | 2.7% margin vs CCRN's -13.0% | |
| Stability / Safety | Beta 0.59 vs INNV's 1.66 | |
| Dividends | 2.4% yield; 25-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +147.9% vs CCRN's -5.4% | |
| Efficiency (ROA) | 3.9% ROA vs CCRN's -19.8%, ROIC 9.2% vs -0.9% |
INNV vs CCRN vs ALHC vs AMN vs UNH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
INNV vs CCRN vs ALHC vs AMN vs UNH — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMN leads in 2 of 6 categories
UNH leads 2 • INNV leads 0 • CCRN leads 0 • ALHC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 591.0x CCRN's $761M. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to CCRN's -13.0%. On growth, AMN holds the edge at +99.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $946M | $761M | $4.3B | $3.4B | $449.7B |
| EBITDAEarnings before interest/tax | $4M | $9M | $66M | $127M | $23.2B |
| Net IncomeAfter-tax profit | -$22M | -$99M | $20M | -$32M | $12.0B |
| Free Cash FlowCash after capex | $39M | $41M | $237M | $714M | $19.7B |
| Gross MarginGross profit ÷ Revenue | +14.8% | +18.2% | +9.0% | +25.5% | +18.8% |
| Operating MarginEBIT ÷ Revenue | +1.5% | -0.9% | +0.8% | +0.3% | +4.2% |
| Net MarginNet income ÷ Revenue | -2.3% | -13.0% | +0.5% | -0.9% | +2.7% |
| FCF MarginFCF ÷ Revenue | +4.1% | +5.4% | +5.6% | +20.9% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.5% | -100.0% | +33.3% | +99.9% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -161.3% | -6.0% | +2.1% | +56.8% | +0.7% |
Valuation Metrics
AMN leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, AMN's 8.6x EV/EBITDA is more attractive than ALHC's 77.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.1B | $423M | $3.7B | $869M | $335.6B |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $317M | $3.5B | $1.6B | $389.6B |
| Trailing P/EPrice ÷ TTM EPS | -36.73x | -4.47x | -4932.43x | -9.06x | 27.95x |
| Forward P/EPrice ÷ next-FY EPS est. | 32.03x | 133.84x | 140.93x | 11.05x | 20.19x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 23.75x | 77.12x | 8.63x | 16.70x |
| Price / SalesMarket cap ÷ Revenue | 1.28x | 0.40x | 0.94x | 0.32x | 0.75x |
| Price / BookPrice ÷ Book value/share | 4.16x | 1.31x | 20.16x | 1.35x | 3.31x |
| Price / FCFMarket cap ÷ FCF | 41.22x | 10.55x | 32.95x | 3.72x | 20.88x |
Profitability & Efficiency
UNH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-27 for CCRN. CCRN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALHC's 1.89x. On the Piotroski fundamental quality scale (0–9), INNV scores 6/9 vs AMN's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -8.2% | -27.1% | +11.5% | -5.0% | +11.5% |
| ROA (TTM)Return on assets | -4.1% | -19.8% | +1.8% | -1.4% | +3.9% |
| ROICReturn on invested capital | -6.8% | -0.9% | — | +1.6% | +9.2% |
| ROCEReturn on capital employed | -7.1% | -0.8% | +2.9% | +2.0% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.38x | 0.01x | 1.89x | 1.25x | 0.77x |
| Net DebtTotal debt minus cash | $37M | -$106M | -$240M | $769M | $54.0B |
| Cash & Equiv.Liquid assets | $64M | $109M | $578M | $34M | $24.4B |
| Total DebtShort + long-term debt | $101M | $2M | $338M | $803M | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | 5.96x | -1.39x | 1.27x | -1.70x | 4.71x |
Total Returns (Dividends Reinvested)
Evenly matched — ALHC and UNH each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UNH five years ago would be worth $9,743 today (with dividends reinvested), compared to $2,488 for AMN. Over the past 12 months, INNV leads with a +147.9% total return vs CCRN's -5.4%. The 3-year compound annual growth rate (CAGR) favors ALHC at 36.2% vs AMN's -37.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +55.7% | +62.4% | -9.7% | +48.7% | +10.6% |
| 1-Year ReturnPast 12 months | +147.9% | -5.4% | +17.6% | +14.6% | -3.2% |
| 3-Year ReturnCumulative with dividends | +24.5% | -44.3% | +152.4% | -75.1% | -19.9% |
| 5-Year ReturnCumulative with dividends | -68.5% | -22.5% | -22.7% | -75.1% | -2.6% |
| 10-Year ReturnCumulative with dividends | -66.6% | -10.5% | +5.4% | -41.5% | +220.6% |
| CAGR (3Y)Annualised 3-year return | +7.6% | -17.7% | +36.2% | -37.1% | -7.1% |
Risk & Volatility
Evenly matched — AMN and UNH each lead in 1 of 2 comparable metrics.
Risk & Volatility
UNH is the less volatile stock with a 0.59 beta — it tends to amplify market swings less than INNV's 1.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMN currently trades 94.7% from its 52-week high vs INNV's 75.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.66x | 0.78x | 0.75x | 1.08x | 0.59x |
| 52-Week HighHighest price in past year | $10.68 | $14.99 | $23.87 | $23.74 | $395.52 |
| 52-Week LowLowest price in past year | $2.85 | $7.43 | $11.63 | $14.87 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +75.7% | +87.3% | +76.5% | +94.7% | +93.5% |
| RSI (14)Momentum oscillator 0–100 | 50.2 | 53.1 | 37.3 | 57.2 | 75.9 |
| Avg Volume (50D)Average daily shares traded | 291K | 552K | 3.6M | 849K | 7.9M |
Analyst Outlook
UNH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: INNV as "Hold", CCRN as "Hold", ALHC as "Buy", AMN as "Buy", UNH as "Buy". Consensus price targets imply 36.1% upside for ALHC (target: $25) vs -18.9% for CCRN (target: $11). UNH is the only dividend payer here at 2.35% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $6.80 | $10.61 | $24.83 | $22.50 | $385.43 |
| # AnalystsCovering analysts | 8 | 14 | 16 | 17 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +2.4% |
| Dividend StreakConsecutive years of raises | 0 | 1 | — | — | 25 |
| Dividend / ShareAnnual DPS | — | — | — | — | $8.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | +1.6% | 0.0% | +0.2% | +1.7% |
AMN leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). UNH leads in 2 (Profitability & Efficiency, Analyst Outlook). 2 tied.
INNV vs CCRN vs ALHC vs AMN vs UNH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is INNV or CCRN or ALHC or AMN or UNH a better buy right now?
For growth investors, Alignment Healthcare, Inc.
(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). UnitedHealth Group Incorporated (UNH) offers the better valuation at 27. 9x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate Alignment Healthcare, Inc. (ALHC) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — INNV or CCRN or ALHC or AMN or UNH?
On forward P/E, AMN Healthcare Services, Inc.
is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — INNV or CCRN or ALHC or AMN or UNH?
Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of -2.
6%, compared to -75. 1% for AMN Healthcare Services, Inc. (AMN). Over 10 years, the gap is even starker: UNH returned +220. 6% versus INNV's -66. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — INNV or CCRN or ALHC or AMN or UNH?
By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.
59β versus InnovAge Holding Corp. 's 1. 66β — meaning INNV is approximately 184% more volatile than UNH relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 189% for Alignment Healthcare, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — INNV or CCRN or ALHC or AMN or UNH?
By revenue growth (latest reported year), Alignment Healthcare, Inc.
(ALHC) is pulling ahead at 46. 1% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — INNV or CCRN or ALHC or AMN or UNH?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.
7% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -3. 5% for INNV. At the gross margin level — before operating expenses — INNV leads at 68. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is INNV or CCRN or ALHC or AMN or UNH more undervalued right now?
On forward earnings alone, AMN Healthcare Services, Inc.
(AMN) trades at 11. 0x forward P/E versus 140. 9x for Alignment Healthcare, Inc. — 129. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALHC: 36. 1% to $24. 83.
08Which pays a better dividend — INNV or CCRN or ALHC or AMN or UNH?
In this comparison, UNH (2.
4% yield) pays a dividend. INNV, CCRN, ALHC, AMN do not pay a meaningful dividend and should not be held primarily for income.
09Is INNV or CCRN or ALHC or AMN or UNH better for a retirement portfolio?
For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
59), 2. 4% yield, +220. 6% 10Y return). InnovAge Holding Corp. (INNV) carries a higher beta of 1. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UNH: +220. 6%, INNV: -66. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between INNV and CCRN and ALHC and AMN and UNH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: INNV is a small-cap quality compounder stock; CCRN is a small-cap quality compounder stock; ALHC is a small-cap high-growth stock; AMN is a small-cap quality compounder stock; UNH is a large-cap quality compounder stock. UNH pays a dividend while INNV, CCRN, ALHC, AMN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.